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INTRODUCTION

An infectious disease, with a confirmed tendency toward recurrence, variously estimated as
bei.ng between fifty and seventy per cent, rheumatic
fever ranks high as a cause of death due to its invariable destructive action upon the heart.

If,

as rarely occurs, the heart is fortunate to escape
damage with the initial attack, it seldom will do so
with the second or third; more commonly, a lesion
primarily incurred will extend with each episode of
renewed activity of the disease.

The careers of many

of these patients develops into a series of battles
with rheumatic activity; with each attack ground
gained in the interval is generally lost.

It is

apparent that measures which will prevent recurrences will maintain cardiac pathology at a minimum
and prolong the life-span of the rheumatic subject.
Prophylactic measures must be directed toward the
eradication of the etiological agent which currently
is suspected as being the Group A hemolytic streptococcus.

The special measures used for t~is purpose

consist chiefly in sulfonamide therapy, vaccination,
tonsillectomy and residence in a suitable climate.
An evaluation of the efficacy of these measures shall
be the purpose of this thesis.
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VACCINES

/
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The working hypothesis upon which intravenous
vaccination for the treatment of rheumatic fever and
the prevention of relapses may be stated as follows:
Assuming that one of the elements in the pathogenesis
of the disease is a condition of hypersensitiveness
to streptococci, then by diminishing or eliminating
that hypersensitive state by intravenous injection
with suitable antigens, one might expect a · corresponding diminution in the sv.mptoms of the disease.
More in detail, one might postulate that hypersensitiveness as a precursor of an acute attack, had
been brought to a certain level by long-standing or repeated low-grade focal infection in which streptococci
of various types had played a leading role.

Then an

acute infection, for example tonsillitis or sinusitis,
acting in or on these somewhat hypersensitiEe tissues,
tends to increase the condition still further so that
eit,her whole bacteria or their disintegration pro-

ducts in exceedingly small amounts act as powerful
irritants.

These irritants appear to attack partic-

ulaPly those mesenchymal tissues most subject to

physiological trauma; hence lesions commonly occur in
such constantly moving structures as joints, tendons,
heart and blood vessels.

Admitting hypersensitiveness to

be only one of several causative elements of the disease,
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it still seems logical to assume that could this condition be diminished and a state of immune hyposensitiveness brought about, then less injury would result

from superinduced infection.
This general working hypothesis has been evolved
chiefly by analogy from investigation of the reactions
of animals to experimental infection with streptococci
under a variety of conditions (2) (7).

It has been

determined that the reactive state of the animals is
conditioned largely by the mode of inoculation:

when

into the tissues, i.e. by production of focal infection,
the resulting state was one of hypersensitiveness, and
subsequent implantation of minute doses of relatively
avirulent microorganisms resulted in extensive injury
and exudation followed by proliferation and repair,
that is the response is one of

11

hyperergic inflammation".

When, on the other hand (37), the preliminary inoculation has been by the intravenous route, subse quent
infection of the tissues was better tolerated, and the
response to suitable doses was a minimum of injury.

In

other words, the immune hyposensitive animal responded
to infection with a minimal disturbance to the local
or general body economy.
It was found that most hypersensitive animals
could be rendered hyposensitive by suitable intravenous
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vaccination (35) (36) and that the most effective
desensitization, or immune hyposetfsitization, was
attained by intravenous /immunization with strains
homologous to the one with which the animals have
been sensitized.
Small (30) (31) prepared a vaccine from a new
species of streptococcus isolated from cultures of
the blood and pharyngeal exudate of rheumatic subjects.

Attempts to use this vaccine to prevent

rheumatic relaps_e s were unsuccesful because of the
ever present danger of over dosage, and the appearance of delayed general reactions which may reach
their height from ten to fourteen days after an
injection.
Wilson et al. (45), in a series of one hundred
twenty-six rheumatic children of comparable age and
intensity of infection, investigated the effect of
intravenous vaccines in preventing recrudescences.
Sixty children were. treated and sixty-six were used
as controls.

The vaccine was a heat-killed culture

of a hemolytic streptococcus suspended in five per
cent phenolized normal salt solution, so that one
cc. represented the required dose.

The first injec-

tion consisted of two hundred fifty thousand microorganisms, and each subsequent injection contained
double the number of that preceding, until the maximum
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of ten million was reached.

This dose was then re-

peated until a total of from nine to twelve treatments
had been given.
Except for short periods of hospitalization in
the beginning of the study, the treatments were given
in the Out-patient Department and the children allowed
to return home where their temperature reactions were
recorded by parents or visiting nurses.

Otherwise the

two groups of ohilaren pursued the same mode of living,
and underwent the same routine medical supervision
and follow-up examination.
The seasonal incidence of recurrences among the
members of the treated and control groups was practically the same before vaccination was instituted.

After

treatment was completed the vaccinat ed group showed
only one-half the number of relapses when compared with
the control groups and also w-ith itself · previous to
the institution of vaccination.

As the only variable

introduced in this group of rheumatic subjects was the
intravenous vaccination with streptococci, it seems
logic al to conclude t h at the dimished incidence of relapses was induced by the vaccines.
In disc ussing the causal relationship between
intravenous vac cination and the diminished incidence
of recurrence observed, three possibilities must be
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considered.
1-

The diminished incidence of recurrence bore
no relation to the vaccination and was merely
coincidental.

2-

'

Vaccination caused stimulation of antibodies,
with resulting increased immunity which was
the result of nonspecific protein irritation
or of specific immunization with hemolytic
streptococci.

3-

Intravenous vaccination resulted in desensitization of the patient to streptococci, and
was not dependent on specific immunization.

Observation of the patients in the previous
series over a three year period (46) made it apparent
that the diminished incidence of recurrence noted at
that time was of short duration.

A number of the

patients of the original series received a second
course of treatment the following year.

One year after

treatment was inaugurated; the incidence of recurrence
was not significantly diminished and two years later
was about the same as that in the controls.

Subjects

who received one course of vaccine exhibited fewer recurrences one year later than the subjects receiving
a second course of treatment.

Two years later the in-

cidence was about the same in both groups.
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This would seem to justify the belief that the diminished incidence of recurrence observed in the original
series was probably not related to treatment.
Typhoid vaccine given to a group of rheumatic
children produced results comparable to those in which
streptococcus vaccine was used.

Furthermore, curves

of the seasonal incidence of recurrence for seventeen
subjects who received polyvalent streptococcus
vaccine were comparable to those of the control series
for the same period of observation.

The incidence of

recurrence for eighteen subjects who received autogenous, individual and pooled streptococcus viridans
vaccine did not show a significant reduction and, as
a matter of fact, there was a trend for the control
series to have fewer reucrrences.
It was evident from the comparable results secured in subjects of the treated and control series
that intravenous treatment with vaccine antigens did
not seem to influence the clinical course of the disease over a p eriod of two to t hree years.

After per-

formin g a similar experiment Stroud (34) reached the
same conclusion.
In 1938 Wasson (44) reopened the vaccination
question.

His vaccine was a stock filtrate of

Streptococcus hemolyticus.

He chose the subcutaneous
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route of administration.

Injections were first

given weekly in graduated doses of .3,

.s,

.9cc.

beginning with a 1:100 dilution, followed by similar
doses of stronger concentrations.

After 12 injections,

a month was allowed to elapse, at the end of which
time .3 cc. of the full strength filtrate was given,
followed at monthly intervals by .6 to .9 cc.

The

latter dose was repeated monthly until the beginning
of June.

The treatment was then discontinued until

September when the whole course was repeated as before.
Ten rheumatic children received inoculations with the
filtrate from September 1933 to June 1935, and twentyfour other children from September 1935 to June 1937.
In each instance thirty-four patients were used as
controls.
Of the thirty-four children treated only two, or
5.9 per cent, developed the disease in its acute phase
during the course of therapy, while the control groups
showed 15 per cent and 43.4 per cent respectively.
The results were so encouraging that Wasson and
Brown (43) undertook the immunization of another group
of children.

They immunized thirty-two new patients,

from October 1937 to June 1939.

During the first winter,

forty-one patients were used as controls, and, during
the second winter, thirty-nine.

-10-

During the first year of treatment, three
vaccinated children, or 9.4 per cent suffered attacks
of acute rheumatic fever while eighteen out of fortyone control subjects suffered from recurrences during
the same year.
During the second year of treatment there was
only one attack of accute rheumatic fever, an incidence
of 3.2 per cent, in the vaccinated group.

Among the

thirty-nine control subjects observed during the second
year, there were eleven attacks of acute rheumatic fever
and sub-acute rheumatic sympto ms were many and troublesome.
A follow-up examination of the patients who were
treated from 1933 to 1935 disclosed that rheumatic fever
had recurred in only two, or seven per cent, during
the interval.

On the other hand, control patients who

had been observed over the same period suffered ten
attacks of rheumatic fever, an incidence of thirtythree per cent~
From these studies, it appears that inoculation
with hemolytic streptococcus filtrate in patients

known to have rheumatic fever continues, after six
years, to have beneficial results, i.e., it reduces
the number of rheumatic fever attacks, 8.lld, consequently, the incidence of carditis.
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Wasson and Brown (42) continued this study during
the 1939 and 1940 seasons, and found a comparable
diminished incidence of recrudescences in treated subjects.

A review of previously treated patients shows

a very low incidence of recurrences in vaccinated
subjects as _compared with the various groups of controls.
Vaccines prepared from heat-killed cultures are
apparently of little value in the prophylaxis of rheumatic recurrences.

On the other hand, subcuta~eous
".---

infections of a filtrate prepared from the same organiam have been proved to markedly lessen the incidence
of recurrent attacks.

I
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TONSILLECTOMY
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The association between rheumatic fever and
tonsillar disease has long been appreciated, and with
the present improved methods for the complete removal of tonsils there has grown up the practice
of removing the tonsils of all rheumatic children.
The object of this chapter is to determine whether
this practice has been shown to be correct, or if
there are indications that it should be modified or
condemned.
St. Lawrence (32) observed forty-two tonsilleotomized children who had previously experienced one
or more attacks of acute rheumatic fever.

The aver-

age period of observation was three and one-half years
after the operation was performed, and the ages of the
subjects varied from four to sixteen years at the time
of the operation.

There was no recurrence of rheu-

matic manifestations in thirty-five cases or eightyfour per cent.

St. Lawrence concluded that tonsil-

lectomy was of definity value in the prevention of
rheumatic recurrences.

However these results could

not be conside red conclusive, because the period of
observation was short and no controls were followed
in conjunction with the work.
Poynton (25) also believes that enucleation of
the tonsils tends to stop severe recurrent throat in-
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fections, which on each occasion lay the rheumatic
subject open to a recrudescence of the disease.
Do recurrent attacks appear as often in children
whose tonsils are removed after the first attack as
in those who are not operated on?
Kaiser (16) observed three hundred-sixteen children who had their first attack before the tonsils were
removed.

Of that number, eighty had one or more recur-

rent attacks of acute rheumatism before their tonsils
were removed, and fifty-six had their second attack
after enucleation of the tonsils.

It was found that

recurrent attacks are by no means prevented when tonsillectomy is performed after the first attack, but
they are likely to occur about ten per cent less often
than in the children who are denied a'A -operation after
the first attack.
Do recrudescences occur as fre quently in children
who had their first attack of rheumatic fever after
the tonsils were removed as in those who had their
first attack before tonsillectomy?
In a survey of two hundred ei ghty-two rheumatic
subjects, Kaiser found that twenty-five per cent of
those who had the first attack after tonsillectomy,
had recurrences while the percentage of recurrences
in children who were operated on after their first
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attack was twenty per cent.

He concluded from

these figures that rheumatic fever, occurring for the
first time in a child who has had the tonsils removed, is more likely to recur than in the patient
who is infected before tonsillectomy.
One hundred and eight patients subjected to
tonsillectomy and adenoidectomy because of rheumatic
fever, between 1910 and 1924, were reinvestigated in
1930 by Allan and Baylor (1).

Following operation

recrudescences of acute rheumatic manifestations occurred in forty-three and five tenths per cent.

This

is somewhat lower than the incidence of recrudescences
reported fro m other localities.

.

Whether the lower

incidence of recrudescences in Allan and Baylor's
series was due to the removal of the tonsils and adenoids or to the locality in which the rheumatic subjects lived could not satisfactorily be determined
because the series was too small to permit s t atistical
deductions.
Wilson, Lingg and Cr oxford (47) prepared an excellent study of four hundred and thirteen rheumatic
children to determine the influence of the tonsils on .
recurrent attacks.

In their survey, a careful

correlation was made between the a ge of tonsillectomy and the age at which recurrent attacks appeared.
It was brought out that recurrences appear in young

-16-

children under nine years of age whether tonsils are
removed or not, while after ten years of age, recurrences are less common in both groups.

Their re-

sults lead to the belief that tonsillectomy should
not ~e advised as a routine therapeutic measure for
the prevention of rheumatic recurrences.
Kaiser (15) also came to the conclusion that
recurrent attacks of rheumatic fever occur as frequently in tonsillectomized children as in untreated
ones.

Robey (?6), on the other hand, believes that

tonsillectomy should be performed on all rheumatic
subjects.

He (27) brings out the fact that :fallure

of this method of prophylaxis is due to the incomplete
removal of tonsillar tissue.
A review of the literature on the value of tonsillectomy in the prevention of the ~ecurrence of
manifestations of the rheumatic syndrome is inconclusive.

The period of ebservation has frequently

been too short and the cases have not been reported
in sufficient detail to follow the course of the
disease in each individual, and in only a few instances were corresponding untreated groups studied
as controls.
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SULFANILAMIDE
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Thomas and France (39) were the first workers
to become interested in the use of sulfallilamide for
the prophylaxis of rheumatic fever recurrences.
Their experiments were carried out during the winters
of 1936-37 and 1937-38.

The subjects observed ranged

in age from fourteen to thirty-six years.

Since no

patients under the age of fourteen years were available, they had no information concerning the prophylactic use of sulfanilamide in childhood.

Sulfanil-

amide was given continuously during the course of
these two winters to thirty individuals.

The drug

was administered daily over a seven months period in
a dosage of fifteen to twenty grains without 111 effects.
None of these treated patients haa a major attack of
acute rheumatic fever or an acute beta hemolytic
streptocoooal infection while taking sulfanilamide.
On the other hand, of thirty control patients, four
developed major attacks of rheumatic fever during the
same period.

These favorable results naturally led

to further research in the use of thie new method fer
the prevention of rheumatic recurrences.
After ten years of observation, Coburn and Moore
(5) noted that rheumatic subjects who escaped hemolytic
streptococcal infections also escaped rheumatic fever.
It therefore seemed possible that the development of
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rheumatic attacks might be avoided if streptococcal
respiratory infections could be prevented.

With this

object in mind, they conducted studies in the prophylaxis of hemolytic streptococcal infections over a
period of two years.

Experiments performed on guinea

pigs showed that sulfanilamide gave complete protection
against spontaneous lymphadenitis with Group C hemolytic streptococci.

It also seemed to protect about

two-thirds of the animaJ.s which received a large dose
of the same organisms intranasally, and modified the
disease in the remaining one-third.

It was then de-

cided to investigate the effect of sulfanilamide, ad ministered during pharyngitis, on the incidence of
rheumatic recrudescences.
The patients were selected from a group of rheumatic subjects ~ho had been under observation for a
number of years.

Each hemolytic streptococcus throat

infection that was seen within twenty -four hours of
the onset of symptoms was treated for five to fourteen days with sulfanilamide.

Patients· who contracted

similar infections, but did not report ~heir symptoms
until after twenty-four hours, were used as controls.
Careful observations were made on this group of forty
'

children and young adults.
Thirteen treated cases and eleven untreated cases .

-20-

developed rheumatic manifestations, however, the latter
were possibly a little more severe.

Sulfanilamide

therapy bega:n after the onset of pharyngitis appeared
to have no effect as a prophylactic agent in preventing rheumatic recrudescences.
The efficacy of sulfanilamide in preventing
guinea pigs from contracting spontaneous Group C infections suggested that it might also be of value in preventing the occurrence of Group A respiratory infections
in human subjects.

To investigate this possibility,

further studies were carried out.

Twenty-nine rheu-

matic girls, between the ages of six and fourteen years,
who were in a convalescent home were selected for the
following investigation.

Each patient was given by

mouth approximately two grams of sulfanilamdie daily
and this medication was maintained for the whole period
of observation.

During the course of the study there

were no drug symptoms, no frank streptococcus infections,
nor any attacks of acute rheumatism.
In the foregoing study which was performed in a
closed colony, there was no indication that the patients
had contact with streptococcus infection other than
their association with two known carriers of this
organism.

A later series of twenty-six subjects, who

were exposed to two patients who had streptococcal
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infections, were living in close proximity with a
carrier of hemolytic streptococci and with six nonmedicated patients who had positive cultures or
rheumatic activity; moreover they were visited by
their families on numerous occasions.

These patients

were given prophylactic doses of two grruns of sulfanilamide per patient per day.

The clinical results showed

that twenty-five out of twenty-six medicated patients
remained free of rheumatic activity, while one patient developed changes which could be interpreted as
active rheumatism.
The general environment of the patients in the
foregoing experiment with respect to nutrition, housing, and rest facilities was much better than that in
which the average rheumatic child in New York City
lives.

Since these factors might have had some bear-

ing -on the results another study was therefore designed
to test the possible protective action of sulfanilamide
under conditions less favorable for the general well-be.ing
of the subjects.

This group consisted of thirty highly

susceptible rheumatic subjects from eight to fourteen
years of age.

All were known to have contr acted fre-

quent streptococcal respiratory infections during previous years of observation.

They were mostly from

families of poor economic status.

Each child re-

ceived between two and three grams of sulfanilamide
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daily during the course of one winter.

Twenty of the

thirty patients who started the study continued medication throughout the course.

The other ten took the

medication only for a part of the whole perfod, and
served as controls.

None of the medicated patients

developed clinical evidence of rheumatic fever,
while three of the ten control patients developed
hemolytic streptococcal upper respiratory infections
which were followed by rheumatic recrudescences.
In a later study of one hundred eighty four subjects by Coburn and Moore (6) two prerequisites were
sought; (a) that each individual had experienced frank
attacks of rheumatic fever with carditis, alld (b)
that each could be under close observation during the
period of study.

Preference was given to children

who had experienced frequent or even annual attacks
since the onset of the disease.

Sulfanilamide in a

dosage of approximately three grams daily was given
to these children.

The blood levels were maintained

at approximately four to five milligrams per cent.
Only one of the one hundred and eighty four subjects
developed a recrudescence of rheumatic fever; the expected indidence of attacks in rheumatic children of
this age group in New York City is approximately
thirty-five per cent.

The only difficulty encountered
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in this series was the development of mild toxic
symptoms in ten per cent of the subjects within a
few days after starting medication.
One factor that was impossible for Coburn and

-

Moore to control in their previous study was the increasing age of the group.

Between 1936 and 1939,

many of the children passed puberty, and as is well
recognized, rheumatic subjects tend to have fewer
recrudescences in adolescence than in early childhood.

It was therefore possible to regard the in-

creasing age of their patients as largely contributory to the decreased incidence of rheumatic fever.
To determine the effect of this age factor, Coburn
and Moore (4) withdrew sulfanilamide from the patients
who received prophylactic doses in the period 1936-1939.
This was done during the winter of 1939-1940 to a group
of one hundred patients, mostly adolescents.

None of

these patients had had streptococcic pharyngitis or
manifestations of rheumatic activity while they received sulfanilamide.

They lived in the same environ-

ment as previously and received the same clinical and
laboratory examinations that were performed i'n the
previous work.

Thirty-two of the_one

hundred patients

contracted hemolytic streptococcic pharyngitis during the first twelve month following the withdrawal of
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sulfanilamide, and in forty percent of these untreated
infected patients rheumatic fever developed.

It was

evident that the absence of rheumatic recrudescences
in the previously treated subjects was due to the
sulfanilamide alld not to a change in susceptibility.
It was also clear that the prophylactic effect of sulfanilamide does not exert any beneficial effect beyond the period of treatment.
Thomas (40), in her study of the prophylactic
use of sulfanilamide in rheumatic individuals, selected a group of adolescents and adults, each of whom
had experienced acute rheumatic fever within three
years of entering the study.

She observed other

patients with similar histories as a control group.
All of the patients were ambulatory and in the quiescent phase of their disease, but they had previously
experienced one or more attacks of polyarthritis or
carditis, or both.

The age variance in this grouw

was from seven to thir~y-seven years.

Treated and

control groups were matched as closely as possible
as to age, sex, race, history of rheumatic fever, and
cardiac lesions.
The treated group were given sulfanilainide daily
from October or November until June.

The first year

the dose given was 15 grains per day in three divided
doses.

The next year the dose was altered to ten
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grai'ns twice daily.

With rare exceptions the same

dosage was given to everyone, regardless of body
weight.
During the four year period of this study, not
a single major attack of rheumatic fever occurred in
any patient while taking sulfanilamide prophylactioally.
In contrast, fifteen major rheumatic epieo·d es were
observed among control patients during the same period,
and five more control patients suffered from acute
illnesses whic.h might have been rheumatic in character.
Thomas also confirmed the observation ·made previously
by Coburn 8lld Moore that sulfanilamide protected
against recurrences only during the period given, and
she l ater (41) suggested that it ts best to give the
suli anilamide the year round rather than omit summer.
Also, smaller daily dosage s used ·-in her series resulted in fewer toxic reaction~ and the clinical results were as good as the high dosage series of other
workers.
Hansen et al. (10) gave sulfanilamide to fiftythree different children for a total of forty-six season- cases.

All subjects studied were between the ages

of three 8lld sixteen and had essentially similar histories as regards previous rheumatic episodes, degree
of cardiac involvement, and social status.

The

ren were observed under conditions which closely

child-
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approximate those encountered in the p r -:hvate practice
of medicine.

Only two of the fifty-three children in

the group treated with a sulfonamide compound experienced a rheumatic flare-up, an4 in one this occurred
within six days after the use of the drug was begun.
On the other hand, seventeen of the thirty-two children in the control gr·oµp had a total of twenty-one
rheumatic recrudescences. . In addition, the treated
patients seemed favorably affected a.s regards the trend
in degree of cardiac ·involvement,

size of the heart

and functional classification.
Kuttner et al. (17) found that during a three
year period of observation of groups of rheumatic
children no relapses were observed in those who _escaped streptococcus upper respiratory infections.
Since, however, 'the total number of rheumatic re~
currences was small it seemed possible that the relationship of the streptococcus pharyngitis to the
reactivation of th.e rheumatic process might have
been accidental.

To rule out this possibility it was

essential to study the effect· of preventing streptococcus upper respiratory infections in rheumatic
subjects by some means which had no immediate influence on the rheumatic infection. itself.

Kuttner

and Krumwiede (18) choose sulfanilamide for this
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purpose, since most observers (38) (21) agree that
this drug not only fails to benefit patients with
active rheumatic fever, but actually tends to increase the severity of the rheumatic symptoms.
Previous studies to determine the efficacy of
prophylactic sulf'anilamide in the prevention of
streptococcus upper respiratory infections and consequently rheumatic recurrences were conducted without an opportunity of comparing the patients who were
receiving sulfanilamide with adequate control groups
living under identical conditions.

It seemed worth

while, therefore, to study t _h e value of sulfanilamide
prophylaxis in an institution with the patients under
daily observation, and careful bacteriological studies
could be made.
Kuttner and Reyersback (18) (19) gave small daily
doses of sulfanilamide to one hundred and eight rheumatic children from October until June during two
successive winters.

Only two of these subjects con-

tracted streptococcus upper respiratory infections,
and only one of them showed signs of rheumatic activity.
Among the one hundred and four children who served as
controls, forty-eight contracted streptococcal
pharyngitis, and t wenty-three of these developed definite rheumatic relapses.

Five additional children
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had laboratory evidence or mild symptoms suggesting
rheumatic activity.

These results are in accord with

those mtntioned previously and suggest that in closed
communities where the spread of streptococcus is difficult to control, prophylactic doses of sulfanilamide
are effective in preventing both streptococcus pharyngitis and the rheumatic relapses which follow.

Mild

toxic symptoms were noted in fifteen per cent of the
medicated patients in this series.
Out of a total of forty-one patient-seasons
covering a two year period, Chandler and Taussig ( 3)
found that only one ~heumatic patient receiving small
doses of sulfanilamide developed a questionalbe recurrence of rheumatic fever.

Among the controls in

the corresponding period of time there were five recurrences of rheumatic fever, or over ten per cent,
and two of the attacks extended into the second season.
A

few patients originally in the medicated group were

withdrawn because mild toxic symptoms developed, however,
no serious reaction such as that reported by Stowell
( 33) was enooUilt ered.

Feldt (9) carried out a program of prophylaxis
among rheumatic patients over a period of two seasons
(1941-42) and (1942-43).

The season extended from

October or November to May or June.

There were thirty-

two children in the control series, and some were in
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this group both years, so that, altogether, fortytwo patient-seasons were represented.

The treated

group consisted of a total of eighty-nine patient-seasons.

Most patients were given fifteen grains of

sulfanilami de daily in three divided doses.

At times

as much as thirty grains or as little as five grains
daily were used, depending on the blood sulfanilamide
level and the presence of toxic sy.mptoms.

An attempt

was made to maintain the blood level between one and
three milligrams per cent, but it ranged from zero
to six and six tenths milligrams per cent.
During the two seasons none of the treated children developed a recurrence of rheumatic fever, while·
among the forty-two con t rol patient-seasons there
were three major and minor rheumatic episodes and twentythree questionable epi sodes.

Toxic sy1mptoms were in-

frequent and unimportant in this series, and Feldt concluded that sulfanilamide is a relatively safe and
effective prophylactic measure against recurrent

rheumatic infection.
Is the use of sulfani.lamide a practical possibil1ty, or does it necessitate so many laboratory procedures that it can only be carried out in centers
of research supported by special funds?

Quite pro-

perly the initial work on this problem has been carried
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out with careful laboratory studies, but these were
by no means necessary to safeguard the welfare of the
patient, nor the undertaking.

Total white blood cell

counts and hemoglobin determinations are the only
routine procedures that must be carried out, and
these should be followed carefully during the early
weeks of treatment, supplementing them with other
blood studies only when the simple counts are found
to be abnormal.
Most of the work done thus far in this phase of
prophylaxis has been performed on comparatively small
series of cases followed for a short period of time;
howeyer, theresults have been uniformly favorable.
It remains to be seen what deleterious effects will
occur from the continuous administration of sulfanilamide over a long period of time.
Since the greater part of recurrences come within
five years of the initial attack, it would seem that
five yearswould be the shortest span of time the drug
should be taken, and for younger children the span
should probably .be longer.

This 1s a difficult task

but with patience and perseverance in careful case
-

following and education of rheumatic patients and their
p arents it oan ·be done on a large scale as well as
with a small group.
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From the foregoing presentation one must conclude
that sulfanilamide, a dministered to the quiescent
rheumatic subject in a dosage of one to two grams
daily, prevents recrudescences of rheumatic fever.
This method of prophylaxis will probably be more
g enerally used in the near future.
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CLIMATE
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Is rheumatic fever a disease which is more
prevalent in one section of the country than another?
If so, in which section or sections is the lowest incidence found?

These are the questions we shall now

attempt to answer; f or if rheumatic patients can be
prevailed upon to moye to locations of known low
incidence, it is possible that the incidence of recurrence of rheumatic attacks may be diminished.
On the baais of hospital admission r ates,
Faulkner and White (8), and later Harrison and Levine

(11), pointed out the fre quency with which patients
with rheumatic fever were recorded in the diagnostic
files of northern hospitals as compared to southern
hospitals.

Using a similar approach, tbe Seegals

(29) (28) found that the yearly admission rate for

rheumatic fever in a selected series of hospitals in
the United States and Canada is definitely greater
in the northern than in the southern regions of the
conti nent.
From mortality statist ics this same general conclusion
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be reached if we use Hedley•s method of

estimating rheumatic mortality from cardiac deaths
Gccurring between the ages of five and twenty-four
years.

In applying this method to the coUDtry at large,

Hedley (12) found that a correcti on for negro. mortality
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was necessary if one were to obtain comparable figures.
This results from the fact that Negroes are more susceptible to rheumatic heart disease than whites; consequently t?e death rates are correspondingly higher
in this race.

When the mortality rates for rheumatic

heart disease of white persons in the •Deep South" are
compared with those for both races in the Middle Atlantic and New England St ates, which are mo.stly white, the
Southern rates are considerably lower than the Northern.
After 10 years of observation, Nichol (23) is convinced that in southern Florida, mild or smouldering
forms of rheumatic carditis is quite uncommon; the
obvious case with arthritis or chorea, very rare.
McLean (20) contradictorily says that the varied manifestatio~s, complic ations, and sequelae so often associated
with rheumatic fever in the North, are more common in
the South than is generally recognized.
Jones et al. (14) sent a number of Boston rheumatic
subjects to Florida for the winter season in an attempt
to determine the effect of .a milder climate on the
course of tbe rheumatic process.

Rheumatic fever and

rheumatic heart disease subjects living in such a
climate, se emed to be protected from recurrences to
some extent, but not invariably.
The bulk of the evidence supports the view that
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rheumatic fever is less prevalent in the southern
section of the United St ates.
Mills (22) in a very good summary of seasonal
Md

regional f actors in rheumatic fever and rheumatic

heart disease, st ates that "attacks occur ten to twenty
times more often in the worst areas of the storm zones
than in the calm warmth of the tropics, 11 and suggests
that,

11

due to rarity of storm changes in the . southwest

United St ates, residen_c e near the Mexican border would
probably be even more beneficial than in southern
Florida".
results

He states that the reason for the better
in the southwest probably lies in the year-

round lack of storms there, as contrasted to a winter
storminess from Texas eastward almost as great as
afflicts the northern st at es.
Many observers agree t hat the type of climate
found in the southw,est United States is beneficial
for rheumatic subjects and classify the following as
the most important factors.
1- An unusually stable barometic pressure with a low degree and frequency
of storminess.
2-

Low precipitation aJ11d humidity.

3- A fairly high mean temperature.
4-

A high percentage of yearly sunshine.
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Paul and Dixon (24) measured the geographic
prevalence of rheumatic heart disease among three
groups of Indian school-children in Northwestern
and Southwestern sections of the United States.
This survey whowed that in the cold, though relatively dry, climate of Wyoming and Montana the
prevalence of rheumatic heart disease is almost
ten t'imes as frequent as it is in the warm, dry
climate of southern Arizona.
Hill and Holbrook (13) report that over a period
of fourteen yearsin the practice of internal ,medici~e,
. with special attention to rheumatic disease, they did
not observe a single recurrence of rheumatic fever in
patients sent to Tuscon, Ari,mna from other parts of
the country.

A few of those who returned later to

their homes 'in the east or north have had recurrences.
They believe that the climate in the southwest United
States -is a specific measure in preventing recurrences
of rheumatic fever.
It appears that rheumatic heart disease is less
prevalent in the southern United States and much less
prevalent in the southwest, particularly Arizona.
Perhaps the ideal measure would be to mov e patients
who have · rheumatic fever to the latter area where this
disease is almost non-existent.
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CONCLUSION
Of the various special measures investigated in
the search for a satisfactory method or preventing
rheumatic recurrences, some have met with considerable
success, while others have proved to be of doubtful
value.
The earliest method and one which today has almost become impirical is tonsillectomy performed in
the quiescent stage following the initial infection.
Although the value of this form of prophylaxis is
manifestly controversial as evidenced by the contradictory nature of experimental reports; nevertheless it has been of little benefit as a specific
form of prophylaxis.
Vaccination with heat-killed cultures of
hemolytic streptococci has proved to be wholly ineffective; on the other had, moderate success has
been obtained through administration of subcutaneous injections of a filtrate of the same organism.
A singularly desirable quality found in the latter
prophylactic measure is its prolonged effect.
The most promising and effectual advance in the
prophylaxis of rheumatic recurrences has unquestionably been the hiemal administration of sulfanilamide.
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Investi gators agree that this drug will prevent recurrences in all but a very small percentage of cases.
The only unfavorable features encountered in this
method are; the toxicity of the dru g to a few individuals and the necessity of its prolonged use.
From the fore going considerations, the author
concludes th at recurrences can be prevented in rheumatic subjects by the universal administration of sulfanilamide during the quiescent phase of the disease.
Best results have been obt ained by the daily use of
two to three grams of the drug ~h»oughout the winter
months.

Routine erythrocyte counts and hemoglobin

determinations are necessa ry in order to forsee and
prevent imminent blood damage.

Should the patient

prove sensitive to sulfanilamide 1 subcutaneous injections of a filtrate of Group A hemolytic streptococci shall be the method of choice.

Lastly, in

cases of favorable circums tances, residence in an
area of low incidence of recurrence, particularly in
Arizona, should be advised.
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